Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
92 /100
CRITICAL RISK
Score updated Oct 13, 2026

WGRX — Wellgistics Health, Inc. Dilution Risk Tracker

Track WGRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WGRX — Get alerts when the score changes →

As of October 13, 2026, Wellgistics Health, Inc. (WGRX) has a DilutionWatch DilutionScore of 92/100, rated CRITICAL dilution risk. Wellgistics Health, Inc. has a market capitalization of $8.60M, 3.06M shares outstanding, 14 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $200.00M, 1.10M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 67%
💰 Capital Raise model 75%
• Critical: only 2.3 months cash remaining
• Active shelf registration ($200M, 2327% of market cap)
📜 Warrant Exercise model 60%
• Massive warrant overhang: 36% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 433% potential dilution
• Convertible risk score very high (85/100)
🔔 Track WGRX — Get forecast alerts →

Market Data

Market Cap$8.60M
Shares Outstanding3.06M
Float2.48M
Cash$2.46M
Debt$31.81M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore92/100DilutionWatch score record
Shares Outstanding3.06MVerified float table or market cache
Public Float2.48MVerified float table or market cache
Market Cap$8.60MMarket data cache
Cash Runway2.3 monthsDilutionWatch score inputs
Shelf Capacity$200.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.10MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, 8-K 1, 8-K/A 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 41.5% shares (2026Q1 vs prior)
14 institutional holders · 2.74M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.21M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 710.8K shares
#3 VANGUARD FIDUCIARY TRUST CO 309.6K shares
+ 11 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-17
xbrl XBRL CONVERTIBLE 2026-08-17
4 INSIDER TRANSACTION 2026-04-23
4 INSIDER TRANSACTION 2026-04-23
8-K/A 8K EVENT 2026-04-21
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual WGRX Dilution Snapshot

Wellgistics Health, Inc. (WGRX) has a DilutionScore of 92/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

WGRX's DilutionScore is currently 92/100 (Critical risk), with 4 score changes tracked over 89 days. The score deteriorated from 99/100 (Critical risk).

Period Score Risk Level Duration
Sep 07 – Oct 13, 202692/100CRITICAL37 days
Sep 03 – Sep 06, 202699/100CRITICAL4 days
Aug 22 – Sep 02, 202693/100CRITICAL12 days
Aug 14 – Aug 21, 2026100/100CRITICAL7 days
Jul 16 – Aug 13, 202690/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

WGRX shares outstanding have decreased 97.6% from 104.87M (Mar 2026) to 2.51M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 20262.51M2.48M▲ 156.46%
May 26, 2026125.67M966.5K▼ 98.01%
May 25, 2026125.67M48.45M▼ 50.27%
May 21, 2026125.67M97.43M▲ 140.60%
May 16, 2026126.65M40.49M▲ 3.60%
May 12, 2026126.65M39.09M▼ 1.45%
May 03, 2026126.65M39.66M▼ 13.44%
May 01, 2026126.65M45.82M▼ 17.23%
Apr 26, 2026126.65M55.36M▲ 2.90%
Apr 24, 2026126.65M53.80M▼ 0.44%
Apr 18, 2026126.65M54.04M▲ 5.72%
Mar 28, 2026104.87M51.11M▲ 24.97%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track WGRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment WGRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking WGRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for WGRX
WGRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.